Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons
Cells · 23.02.2024 · 13 (5) · 384
DOI: 10.3390/cells13050384 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 23.02.2024. Verfasst von Musaddique Hussain und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Asthma. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIH.
Abstract (Originalsprache)
Asthma is a prevalent chronic non-communicable disease, affecting approximately 300 million people worldwide. It is characterized by significant airway inflammation, hyperresponsiveness, obstruction, and remodeling. Eosinophilic asthma, a subtype of asthma, involves the accumulation of eosinophils in the airways. These eosinophils release mediators and cytokines, contributing to severe airway inflammation and tissue damage. Emerging evidence suggests that targeting eosinophils could reduce airway remodeling and slow the progression of asthma. To achieve this, it is essential to understand the immunopathology of asthma, identify specific eosinophil-associated biomarkers, and categorize patients more accurately based on the clinical characteristics (phenotypes) and underlying pathobiological mechanisms (endotypes). This review delves into the role of eosinophils in exacerbating severe asthma, exploring various phenotypes and endotypes, as well as biomarkers. It also examines the current and emerging biological agents that target eosinophils in eosinophilic asthma. By focusing on these aspects, both researchers and clinicians can advance the development of targeted therapies to combat eosinophilic pathology in severe asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
ORCID-Profile: Gang Liu
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIH
Zitieren
APA
Hussain, M., & Liu, G. (2024). Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons. Cells, 13(5), 384. https://doi.org/10.3390/cells13050384
Vancouver
Hussain M, Liu G. Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons. Cells. 2024;13(5):384. doi:10.3390/cells13050384
BibTeX
@article{Hussain2024,
author = {Hussain, Musaddique and Liu, Gang},
title = {Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons},
journal = {Cells},
year = {2024},
volume = {13},
number = {5},
pages = {384},
doi = {10.3390/cells13050384}
}
EUVIMED